BIZZARI JEAN-PIERRE — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

BIZZARI JEAN-PIERRE has filed 2 SEC Form 4 filings across 2 companies in the last 90 days.

Profile

BIZZARI JEAN-PIERRE

Jean-Pierre Bizzari is a business executive who serves as a director on the board of ADC Therapeutics SA. The SEC filing context provided lists him specifically as a Director for ADC Therapeutics SA as of June 3, 2026. Beyond this SEC context, there is no additional background information supplied here about his prior roles, education, or affiliations. ADC Therapeutics SA is a biopharmaceutical company focused on developing antibody-drug conjugates for cancer therapy.

RoleDirector
Notability40/100

Board memberships

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-06-17APREAprea Therapeutics, Inc.A — Grant or award3.1K$0.00
2026-06-03ADCTADC Therapeutics SAF — Tax withholding / forfeiture12.6K$3.08$39K
2026-06-03ADCTADC Therapeutics SAA — Grant or award45.0K$0.00

Companies — Last 90 Days

Frequently Asked Questions

Who is BIZZARI JEAN-PIERRE?

Jean-Pierre Bizzari is a business executive who serves as a director on the board of ADC Therapeutics SA. The SEC filing context provided lists him specifically as a Director for ADC Therapeutics SA as of June 3, 2026. Beyond this SEC context, there is no additional background information supplied here about his prior roles, education, or affiliations. ADC Therapeutics SA is a …

How many SEC Form 4 filings has BIZZARI JEAN-PIERRE submitted recently?

2 primary Form 4 filings in the last 90 days, covering 2 companies.

Where can I see all of BIZZARI JEAN-PIERRE's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live BIZZARI JEAN-PIERRE profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.